Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2012 Feb;2(2):115-6.
doi: 10.1158/2159-8290.CD-11-0356.

New roles opined for OPCML

Affiliations
Comment

New roles opined for OPCML

Sherry Y Wu et al. Cancer Discov. 2012 Feb.

Abstract

OPCML, frequently inactivated in ovarian tumors, mediates its antitumor effect via binding to the extracellular domains of several important oncogenic receptor tyrosine kinases (RTK). This, in turn, leads to the downregulation of RTKs in tumor cells and results in significant inhibition of tumor growth.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Schematic illustration of the mechanism by which rOPCML mediates its anti-tumor effect in OPCML-negative cells.

Comment on

References

    1. McKie AB, Vaughan S, Zanini E, Okon IS, Louis L, de Sousa C, et al. The OPCML tumor suppressor functions as a cell surface repressor-adaptor, negatively regulating receptor tyrosine kinases in epithelial ovarian cancer. Cancer Discov. 2012 XXXXX. - PMC - PubMed
    1. Wick M, Fan G, Loh H. Expression of OBCAM-related cDNA clones in Cos 1 cells: evidence for a phosphatidylinositol linkage to the cell membrane. Brain Res Mol Brain Res. 1996;36:322–8. - PubMed
    1. Fleming J, McQuillan H, Millier M, Sellar G. Expression of ovarian tumour suppressor OPCML in the female CD-1 mouse reproductive tract. Reproduction. 2009;137:721–6. - PMC - PubMed
    1. Sellar G, Watt K, Rabiasz G, Stronach E, Li L, Miller E, et al. OPCML at 11q25 is epigenetically inactivated and has tumor-suppressor function in epithelial ovarian cancer. Nat Genet. 2003;34:337–43. - PubMed
    1. Cui Y, Ying Y, van Hasselt AN, Ng KM, Yu J, Zhang Q, et al. OPCML is a broad tumor suppressor for multiple carcinomas and lymphomas with frequently epigenetic inactivation. PLoS One. 2008;3:e2990. - PMC - PubMed

MeSH terms

Substances